X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
prostate cancer (88) 88
index medicus (77) 77
humans (51) 51
male (49) 49
ga-psma (45) 45
pet/ct (37) 37
radiology, nuclear medicine & medical imaging (37) 37
positron emission tomography computed tomography (36) 36
aged (32) 32
ga-psma pet/ct (31) 31
medicine & public health (30) 30
cancer (26) 26
edetic acid - analogs & derivatives (25) 25
imaging / radiology (25) 25
prostatic neoplasms - diagnostic imaging (24) 24
nuclear medicine (23) 23
prostate (23) 23
radiopharmaceuticals (23) 23
tomography (21) 21
diagnosis (20) 20
oncology (19) 19
computed tomography (18) 18
middle aged (18) 18
pet (18) 18
oligopeptides (17) 17
positron emission (17) 17
ga-68-psma (16) 16
orthopedics (16) 16
prostatic neoplasms - pathology (16) 16
cardiology (15) 15
metastasis (15) 15
patients (14) 14
prostate-specific antigen (14) 14
psma (14) 14
68 ga-psma (13) 13
care and treatment (13) 13
metastases (13) 13
organometallic compounds (13) 13
ga-68-psma pet/ct (12) 12
psa (12) 12
ct imaging (11) 11
ga-68-psma pet (11) 11
pet imaging (11) 11
prostata (11) 11
urologic and male genital diseases (11) 11
antigens (10) 10
carcinoma (10) 10
gallium radioisotopes (10) 10
positron-emission tomography (10) 10
68 ga-psma pet/ct (9) 9
antigen (9) 9
biochemical recurrence (9) 9
lesions (9) 9
medical imaging (9) 9
positron emission tomography (9) 9
therapy (9) 9
68ga-psma (8) 8
aged, 80 and over (8) 8
bone neoplasms - diagnostic imaging (8) 8
incidental findings (8) 8
ligand (8) 8
radical prostatectomy (8) 8
usage (8) 8
adenocarcinoma (7) 7
biopsy (7) 7
bone neoplasms - secondary (7) 7
expression (7) 7
krebs (7) 7
pitfall (7) 7
prostate-specific antigen - metabolism (7) 7
prostate-specific membrane antigen (7) 7
radiotherapy (7) 7
tomography, x-ray computed (7) 7
68ga-psma pet/ct (6) 6
adenocarcinoma - diagnostic imaging (6) 6
diagnostic systems (6) 6
health aspects (6) 6
membrane antigen (6) 6
multimodal imaging (6) 6
prostatectomy (6) 6
research (6) 6
tumors (6) 6
adenocarcinoma - pathology (5) 5
analysis (5) 5
antigens, surface - metabolism (5) 5
biochemical relapse (5) 5
bone (5) 5
carcinoma - diagnostic imaging (5) 5
choline (5) 5
gleason score (5) 5
glutamate carboxypeptidase ii - metabolism (5) 5
liver (5) 5
medical physics. medical radiology. nuclear medicine (5) 5
membran (5) 5
membrane antigen-expression (5) 5
neoplasm metastasis (5) 5
prostatic neoplasms - surgery (5) 5
retrospective studies (5) 5
68ga-psma pet (4) 4
[ (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 7/2015, Volume 42, Issue 8, pp. 1284 - 1294
To assess the association between PSA levels, PSA kinetics and other factors and a pathological 68Ga-PSMA PET/CT scan in patients with recurrent prostate... 
68 Ga-PSMA PET/CT | Biochemical relapse | Salvage radiotherapy | Medicine & Public Health | Orthopedics | PSA doubling time | Oncology | Nuclear Medicine | Imaging / Radiology | Cardiology | Recurrent prostate cancer | Ga-PSMA PET/CT
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 1/2016, Volume 43, Issue 1, pp. 34 - 41
Radiotherapy is the main therapeutic approach besides surgery of localized prostate cancer. It relies on risk stratification and exact staging. This report... 
Radiotherapy planning | Medicine & Public Health | 68 Ga-PSMA ligand PET/CT | Orthopedics | Individualized radiotherapy | Oncology | Nuclear Medicine | Imaging / Radiology | Cardiology | Prostate cancer | Ga-PSMA ligand PET/CT | 68Ga-PSMA ligand PET | Original
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 03/2018, Volume 59, Issue 3, pp. 434 - 441
In this prospective survey of referring physicians, we investigated whether and how Ga-labeled prostate-specific membrane antigen 11 ( Ga-PSMA-11) PET/CT... 
Ga-PSMA | Impact on implemented management | Biochemical recurrence | Prostate cancer | PET/CT
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 1/2016, Volume 43, Issue 1, pp. 70 - 83
To evaluate the reproducibility of the combination of hybrid PET/MRI and the 68Ga-PSMA-11 tracer in depicting lymph node (LN) and bone metastases of prostate... 
68 Ga-PSMA | PSMA | PET/MRI | Medicine & Public Health | Lymph node metastases | Orthopedics | PET/CT | Oncology | Nuclear Medicine | Imaging / Radiology | Cardiology | Bone metastases | Ga-PSMA
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 7/2016, Volume 43, Issue 7, pp. 1288 - 1299
We aim to investigate the pharmacokinetics and distribution of the recently clinically introduced radioligand 68Ga-PSMA-11 in men with recurrent prostate... 
Prostate-specific membrane antigen (PSMA) | Medicine & Public Health | Orthopedics | Oncology | 68 Ga-PSMA-ligand PET/CT | Prostate cancer recurrence | Nuclear Medicine | Imaging / Radiology | Cardiology | PSA | Two-tissue compartment model | Ga-PSMA-ligand PET/CT
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 09/2019, pp. 1 - 10
Purpose The present study is based on a retrospective analysis of Gallium-68 (68Ga)-labelled prostate-specific membrane antigen (68Ga-PSMA I&T) PET/CT... 
Antigens | Gallium | Lymphatic system | Risk groups | Health risks | Risk | Metastasis | Disease control | Lymph nodes | Metastases | Histopathology | Computed tomography | Biopsy | Prostate cancer | Prostate | Tumors | Cancer | Lymph
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 06/2018, Volume 45, Issue 6, pp. 904 - 912
Purpose The aims of this retrospective analysis were to compare 68Ga-PSMA PET findings and low-dose CT findings (120 kV, 30 mA), and to obtain semiquantitative... 
Prostate cancer bone metastases | SUV | Ga-PSMA PET/CT | PSA | Two-tissue compartment model | Medical imaging | Positron emission | Association analysis | Metastasis | Pelvis | Patients | Metastases | Bone cancer | Computed tomography | Internalization | Diagnostic software | Tomography | Plasma levels | Diagnostic systems | Bone | Lesions | Prostate cancer | Prostate | Cancer
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 2019, Volume 46, Issue 5, pp. 1054 - 1062
Purpose To evaluate the use of 68Ga-PSMA PET/CT for monitoring response to 177Lu-617 PSMA radioligand therapy in patients with metastatic castrate-resistant... 
Response monitoring | Lu-PSMA-617 | Ga-PSMA PET/CT | Prostate cancer | Therapy | Sensitivity analysis | Statistical analysis | Positron emission | Metastasis | Patients | Survival | Metastases | Sensitivity | Castration | Computed tomography | Lutetium isotopes | Tomography | Prostate | Monitoring | Cancer
Journal Article
World Journal of Urology, ISSN 0724-4983, 2018, Volume 37, Issue 5, pp. 813 - 821
Background 68Ga-PSMA Positron Emission Tomography/Computerized Tomography (PET/CT) has shown promising results for the detection of recurrent prostate cancer... 
PET-CT | Ga-PSMA | PSA velocity | PSA doubling time | Recurrent prostate cancer | PSA | Medical imaging | Computed tomography | Biopsy | Tomography | Positron emission tomography | Prostate | Prostate cancer | Lymph nodes | Tumors | Metastases
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 10/2019, Volume 46, Issue 11, pp. 2280 - 2288
Purpose The role of 68Ga-PSMA PET/CT in the staging of prostate cancer is well known. PSMA is also overexpressed in the neovasculature of other tumours... 
Medical imaging | Positron emission | Management | Metastases | Computed tomography | Kidney cancer | Tomography | Diagnostic systems | Lesions | Prostate cancer | Prostate | Clear cell-type renal cell carcinoma | Tumors | Cancer
Journal Article
Nuclear Medicine Communications, ISSN 0143-3636, 10/2018, Volume 39, Issue 10, pp. 871 - 880
Journal Article
Nuclear Medicine Communications, ISSN 0143-3636, 02/2017, Volume 38, Issue 2, pp. 149 - 155
Journal Article
Clinical Nuclear Medicine, ISSN 0363-9762, 02/2017, Volume 42, Issue 2, pp. e126 - e127
ABSTRACTThe potential applications of Ga-labeled prostate-specific membrane antigen (PSMA) PET/CT in the imaging of prostate cancer are now well established. A... 
multiple myeloma | Ga-PSMA | Lu-PSMA | F-FDG PET/CT | Multiple Myeloma - diagnostic imaging | Organometallic Compounds | Positron Emission Tomography Computed Tomography | Humans | Adult | Male | Radiopharmaceuticals
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.